GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SanBio Co Ltd (TSE:4592) » Definitions » Pretax Margin %

SanBio Co (TSE:4592) Pretax Margin % : % (As of Jan. 2024)


View and export this data going back to 2015. Start your Free Trial

What is SanBio Co Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. SanBio Co's Pre-Tax Income for the three months ended in Jan. 2024 was 円-800.10 Mil. SanBio Co's Revenue for the three months ended in Jan. 2024 was 円0.00 Mil. Therefore, SanBio Co's pretax margin for the quarter that ended in Jan. 2024 was %.

The historical rank and industry rank for SanBio Co's Pretax Margin % or its related term are showing as below:


TSE:4592's Pretax Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -154.52
* Ranked among companies with meaningful Pretax Margin % only.

SanBio Co Pretax Margin % Historical Data

The historical data trend for SanBio Co's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SanBio Co Pretax Margin % Chart

SanBio Co Annual Data
Trend Jan15 Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24
Pretax Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,153.00 - - - -

SanBio Co Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Pretax Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of SanBio Co's Pretax Margin %

For the Biotechnology subindustry, SanBio Co's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SanBio Co's Pretax Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SanBio Co's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where SanBio Co's Pretax Margin % falls into.



SanBio Co Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

SanBio Co's Pretax Margin for the fiscal year that ended in Jan. 2024 is calculated as

Pretax Margin=Pre-Tax Income (A: Jan. 2024 )/Revenue (A: Jan. 2024 )
=-2542.135/0
= %

SanBio Co's Pretax Margin for the quarter that ended in Jan. 2024 is calculated as

Pretax Margin=Pre-Tax Income (Q: Jan. 2024 )/Revenue (Q: Jan. 2024 )
=-800.101/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SanBio Co  (TSE:4592) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.


SanBio Co Pretax Margin % Related Terms

Thank you for viewing the detailed overview of SanBio Co's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


SanBio Co (TSE:4592) Business Description

Traded in Other Exchanges
Address
8-1 Street Luke Tower 32nd Floor, Akashi-cho, Chuo-ku, Tokyo, JPN, 104-0044
SanBio Co Ltd is engaged in the research and development of regenerative cells drugs. The company has three types of drugs under development, including nerve regeneration cell SB623, used for the treatment of chronic cerebral infarction, traumatic brain injury, age-related macular degeneration, retinitis pigmentosa, Parkinson's disease, spinal cord injury and Alzheimer's disease; enhanced type-mesenchymal stem cells SB618, used to treat peripheral neuropathy, as well as muscle stem cells SB308, used in the treatment of muscular dystrophy.

SanBio Co (TSE:4592) Headlines

No Headlines